Shenfu Injection Adjunct with Platinum-Based Chemotherapy for the Treatment of Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis and Systematic Review
Platinum-based chemotherapy is one of the standard treatments for non-small-cell lung cancer (NSCLC), while its high toxicity and limited clinical effects raise big concerns. Shenfu injection (SFI) has been commonly used as an adjutant chemotherapy drug for NSCLC in China. We ascertained the benefic...
Main Authors: | Ailing Cao, Hailang He, Mengxin Jing, Beibei Yu, Xianmei Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2017/1068751 |
Similar Items
-
Huisheng Oral Solution Adjunct With Platinum-Based Chemotherapy for the Treatment of Advanced Non–Small Cell Lung Cancer: A Meta-Analysis and Systematic Review
by: Jingyi Huang, et al.
Published: (2020-09-01) -
Xiao-ai-ping injection adjunct with platinum-based chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis
by: Fanchao Feng, et al.
Published: (2020-01-01) -
Disodium Cantharidinate and Vitamin B6 Injection Adjunct with Platinum-Based Chemotherapy for the Treatment of Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis
by: Zhichao Wang, et al.
Published: (2019-01-01) -
Meta-Analysis of Therapy of Cinobufacini Capsule Adjunct with First-Line Platinum-Based Chemotherapy for the Treatment of Advanced NSCLC
by: Wenpan Peng, et al.
Published: (2021-01-01) -
Shenfu Injection for Intradialytic Hypotension: A Systematic Review and Meta-Analysis
by: Yenan Mo, et al.
Published: (2014-01-01)